Among the previously known variants, 7 % (3/43) are considered Mendelian pathogenic mutations for PD (LRRK2 p.G2019S, PINK1 p.R492X and PARK2 p.D53X) (Table 4). This evidence concerns the gene PRKN and Parkinson disease.